Daehwa Pharmaceutical (067080) surged in after-hours trading held after the regular session closed on the 8th.

In after-hours trading that day, Daehwa Pharmaceutical finished at 13,960 won, up 1,830 won (+15.09%) from the previous trading day. After the regular session ended, it extended its gains further, approaching the 14,000 won level.

With the stock posting a double-digit gain in off-hours trading ahead of the holiday, attention is focused on whether the upward momentum will continue on the first trading day of the new week after the holiday ends. The key point to watch is whether the elevated price level seen in after-hours trading can be maintained in the regular session of the new week.

Meanwhile, Daehwa Pharmaceutical announced on the 8th that 'Liporaxel' has received additional approval from China's National Medical Products Administration (NMPA) for the treatment of patients with recurrent or metastatic HER2-negative breast cancer.

[This article is for investment reference purposes only, and investment decisions and any resulting responsibility rest with the investor.]